Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPTOMYCIN Cause Treatment failure? 190 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Treatment failure have been filed in association with DAPTOMYCIN (daptomycin). This represents 2.1% of all adverse event reports for DAPTOMYCIN.

190
Reports of Treatment failure with DAPTOMYCIN
2.1%
of all DAPTOMYCIN reports
65
Deaths
77
Hospitalizations

How Dangerous Is Treatment failure From DAPTOMYCIN?

Of the 190 reports, 65 (34.2%) resulted in death, 77 (40.5%) required hospitalization, and 4 (2.1%) were considered life-threatening.

Is Treatment failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 190 reports have been filed with the FAERS database.

What Other Side Effects Does DAPTOMYCIN Cause?

Off label use (791) Drug ineffective (658) Product use in unapproved indication (654) Eosinophilic pneumonia (575) Acute kidney injury (501) Blood creatine phosphokinase increased (461) Pyrexia (447) Eosinophilia (405) Rhabdomyolysis (383) Drug reaction with eosinophilia and systemic symptoms (307)

What Other Drugs Cause Treatment failure?

METHOTREXATE (14,672) ETANERCEPT (11,893) ADALIMUMAB (9,990) ABATACEPT (9,301) RITUXIMAB (9,217) TOCILIZUMAB (9,097) HYDROXYCHLOROQUINE (8,786) LEFLUNOMIDE (8,686) INFLIXIMAB (8,535) SULFASALAZINE (7,423)

Which DAPTOMYCIN Alternatives Have Lower Treatment failure Risk?

DAPTOMYCIN vs DARATUMUMAB DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ DAPTOMYCIN vs DARBEPOETIN ALFA DAPTOMYCIN vs DARIDOREXANT DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE

Related Pages

DAPTOMYCIN Full Profile All Treatment failure Reports All Drugs Causing Treatment failure DAPTOMYCIN Demographics